A--NIH NeuroBioBank Brain and Tissue Repository
ID: 75N95024R00124Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (AN11)

Original Source

https://sam.gov/opp/71225917c70545468f9384f152b74eec/view
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the NIH NeuroBioBank Brain and Tissue Repository project. The objective is to acquire post-mortem human brain tissue from a diverse range of donors, including those with various neurological, psychiatric, and neurodevelopmental disorders, to support research efforts in these fields. This initiative is crucial for enhancing the understanding and treatment of such disorders, with the NIH aiming to support multiple awardees capable of acquiring between 70 to 150 unique human donors annually over a five-year contract period. Interested parties should contact Rieka N. Plugge at rieka.plugge@nih.gov or +1 301 827 7515 for further details, with proposals expected to be submitted electronically via the eCPS website following the solicitation release, anticipated within 15 days of this notice.

    Point(s) of Contact
    PLUGGE, RIEKA N
    +1 301 827 7515
    rieka.plugge@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    A--NIH NeuroBioBank Brain and Tissue Repository
    Currently viewing
    Presolicitation
    Similar Opportunities
    Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institute of Mental Health (NIMH), is seeking proposals for scientific management and support services for the National Institute of Mental Health Repository and Genomics Resource (NRGR). The primary objective of this procurement is to sustain, enhance, and enrich the NRGR, which provides critical biospecimens and associated data for research on psychiatric disorders, thereby facilitating genetic and cellular studies. This initiative is vital for advancing scientific understanding of the genetic risk factors and biological mechanisms underlying mental health conditions. Proposals are due by October 21, 2024, with the contract expected to commence on March 1, 2025, and run for a base period of one year, followed by four optional extension periods. Interested parties can direct inquiries to Sarah Adan at sarah.adan@nih.gov or Valerie Whipple at valerie.whipple@nih.gov.
    A--Request for Proposals - Phase I Clinical Trials
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Phase I Clinical Trials focused on the development of small molecule and biologics therapeutics. The objective is to engage qualified contractors to conduct comprehensive clinical trials, including protocol development, trial management, and reporting to regulatory agencies, with a specific emphasis on safety, tolerability, and pharmacokinetics of investigational drugs. This initiative is crucial for advancing therapeutic development in neurological disorders and ensuring compliance with federal regulations regarding human subjects. Proposals are due by October 11, 2024, with a contract performance period extending from April 1, 2025, to March 31, 2035, and a maximum contract value of $233,227,446. For further inquiries, interested parties may contact Evan C. Feely at evan.feely@nih.gov or +1 301 827 5301.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under Request for Proposal (RFP) No. 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, regulate, and distribute a variety of drug compounds essential for advancing research on drug abuse and addiction, including controlled and uncontrolled substances such as morphine, methadone, and various cannabinoid preparations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, is crucial for supporting the drug abuse research community by ensuring the availability of authentic drug products while adhering to federal regulations. Proposals must be submitted electronically by November 15, 2024, and interested parties can contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    A--BPCA Pediatric Trials Network
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for an Indefinite Quantity Contract to establish and maintain an infrastructure for conducting pediatric clinical trials under the Best Pharmaceuticals for Children Act (BPCA). The primary objective of this procurement is to advance pediatric drug development by ensuring compliance with federal regulations and ethical standards in clinical research, including the protection of human subjects and quality control measures. This initiative is crucial for enhancing the understanding and safety of medications for children, thereby improving healthcare outcomes in pediatric populations. Proposals are due by November 4, 2024, with a performance period extending from May 19, 2025, to May 18, 2033, and a funding range between $2,500 and $149 million, contingent on successful contract performance. Interested parties can contact Elizabeth J. Osinski at eo43m@nih.gov or by phone at 240-550-5028 for further information.
    A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are soliciting proposals from small businesses for the Small Business Innovation Research (SBIR) program, aimed at fostering innovative research that aligns with their mission needs. This solicitation, identified as PHS-2025-1, invites proposals across a wide range of health-related topics, including cancer research, aging, infectious diseases, and mental health, with the goal of stimulating technological innovation and enhancing commercialization in the healthcare sector. Eligible small businesses are encouraged to demonstrate the technical feasibility and commercial potential of their projects, with a closing date for proposal submissions set for October 18, 2024. For further inquiries, interested parties can contact Callie Prassinos at Callie.Prassinos@NIH.gov or Julie Rodriguez at ncioasbir@mail.nih.gov.
    DRAFT Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) exploration topic. This initiative aims to enhance access to curative cell therapies for pediatric patients with rare genetic diseases by developing novel quality assurance mechanisms at Academic Medical Centers (AMCs) over a structured 24-month program. The program will focus on identifying manufacturing variability, improving batch quality through signature identification methodologies, and creating statistical tools to guide production decisions, ultimately streamlining the development of small batch autologous cell therapies. Proposals are due by October 22, 2024, and interested parties should direct inquiries to the designated email address provided in the solicitation.
    Clinical Research Operations and Management System (CROMS) v2.0
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) National Institute on Aging (NIA), is seeking responses for the Clinical Research Operations and Management System (CROMS) v2.0 through a Sources Sought notice. The primary objective is to enhance and maintain the CROMS, which supports the management of over 1,000 clinical trials and 3,000 active grants, by providing comprehensive administrative and scientific information management. This initiative is critical for advancing research on aging and ensuring compliance with federal regulations while leveraging advanced technologies such as cloud services and AI for efficient data handling and reporting. Interested parties must submit their responses electronically to Karen Mahon at karen.mahon@nih.gov by 9:00 a.m. Eastern on October 15, 2024, with an industry day scheduled for October 28, 2024.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for the NIAID Clinical Products Center (CPC) contract, aimed at supporting clinical trials focused on immunologic, infectious, and allergic diseases. The contract will provide essential pharmacy and pharmaceutical oversight for national and international clinical trials, ensuring product integrity, participant safety, and compliance with regulatory standards, while also expanding support for additional NIH-funded trials and emergency public health programs as needed. This initiative is critical for advancing research in various immune-mediated diseases, including asthma, autoimmune disorders, and organ transplant rejection. Interested parties should prepare to submit proposals electronically via the NIAID electronic Contract Proposal Submission (eCPS) website, with the presolicitation notice expected to be published on or around October 18, 2024. For further inquiries, contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.
    IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the Immune Epitope Database and Analysis Program, aimed at enhancing research capabilities related to infectious diseases, allergies, and autoimmunity. The program seeks to provide a comprehensive resource for researchers to explore data on antibody and T-cell epitopes, with a focus on maintaining high standards of compliance and transparency in research practices. Proposals are due by November 19, 2024, with a base performance period from October 15, 2025, to October 14, 2026, and potential extensions for up to four additional years. Interested parties can contact Brandon de White at whitebra@niaid.nih.gov or Tom Bahrami at bahramit@niaid.nih.gov for further information.